SEPT9_V1 protein expression is associated with human cancer cell resistance to microtubule disrupting agents

Cancer Biology and Therapy

Volumn 6, Issue 12, 2007, Pages 1926-1931

  Amir, Sharon ^a   Mabjeesh, Nicola J ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

2 methoxyestradiol; Cancer; HIF; Microtubules; Paclitaxel; SEPT9; Septins

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 2 METHOXYESTRADIOL; BIOLOGICAL MARKER; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PACLITAXEL; PROTEIN SEPT9 V1; SEPTIN; TANESPIMYCIN;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MICROTUBULE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

EID: 42549140770     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.12.4971     Document Type: Article

References (39)